Search by Drug Name or NDC

    NDC 55111-0399-30 Lansoprazole 30 mg/1 Details

    Lansoprazole 30 mg/1

    Lansoprazole is a ORAL CAPSULE, DELAYED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Dr.Reddy's Laboratories Ltd.. The primary component is LANSOPRAZOLE.

    Product Information

    NDC 55111-0399
    Product ID 55111-399_c8eb1d41-1fd2-7c06-486c-e6abf08faa6d
    Associated GPIs 49270040006520
    GCN Sequence Number 030107
    GCN Sequence Number Description lansoprazole CAPSULE DR 30 MG ORAL
    HIC3 D4J
    HIC3 Description PROTON-PUMP INHIBITORS
    GCN 01698
    HICL Sequence Number 008993
    HICL Sequence Number Description LANSOPRAZOLE
    Brand/Generic Generic
    Proprietary Name Lansoprazole
    Proprietary Name Suffix n/a
    Non-Proprietary Name lansoprazole
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, DELAYED RELEASE
    Route ORAL
    Active Ingredient Strength 30
    Active Ingredient Units mg/1
    Substance Name LANSOPRAZOLE
    Labeler Name Dr.Reddy's Laboratories Ltd.
    Pharmaceutical Class Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA091269
    Listing Certified Through 2024-12-31

    Package

    NDC 55111-0399-30 (55111039930)

    NDC Package Code 55111-399-30
    Billing NDC 55111039930
    Package 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (55111-399-30)
    Marketing Start Date 2010-10-15
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 82174fcc-1b0f-2068-7fc4-db335b43b5e2 Details

    Revised: 3/2022